PP_1170x120_10-25-21

Reeqonus

Dr. Reddy’s files application for COVID treatment in Canada

Dr. Reddy’s files application for COVID treatment in Canada

MISSISSAUGA, Ontario — Dr. Reddy’s has filed an application  for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Reeqonus is also known as Avigan, which was developed by Fujifilm Toyama Chemical

Adheris Health